1. 抗体
  2. 一抗
  3. 多克隆抗体 修饰型抗体
  4. phospho-PI3 Kinase p110 beta (Ser1070) 抗体

phospho-PI3 Kinase p110 beta (Ser1070) 抗体

目录号: HY-P81211
COA 抗体使用指南 技术支持

phospho-PI3 Kinase p110 beta (Ser1070) Antibody 是一个兔来源、无偶联标记、抗磷酸化 PI3 Kinase p110 beta (Ser1070) 的 IgG 多克隆抗体。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
10 μL ¥470 In-stock
50 μL ¥1220 In-stock
100 μL ¥2000 In-stock
250 μL   询价  

* Please select Quantity before adding items.

  • WB: 蛋白质免疫印迹;
  • IHC-P: 石蜡切片样本的免疫组织化学;
  • IHC-F: 冰冻切片样本的免疫组织化学;
  • ICC/IF: 细胞免疫荧光;
  • IF-Tissue: 组织免疫荧光;
  • mIHC: 多重荧光免疫组化;
  • IP: 免疫沉淀;
  • ChIP: 染色质免疫沉淀;
  • FC: 流式细胞术;
  • ELISA: 酶联免疫吸附试验
  • 产品详情

  • 验证图片

  • 背景信息

  • 产品资料

描述

phospho-PI3 Kinase p110 beta (Ser1070) Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to phospho-PI3 Kinase p110 beta (Ser1070).

宿主

Rabbit

克隆性

Polyclonal

分子量
Predicted band size: 110-123 kDa;
Observed band size: 110 kDa
请注意:因蛋白存在修饰或聚体等情况,以实测为准,预测仅为参考。
反应种属
Human, Mouse, Rat 预测反应种属: Chicken, Dog, Pig, Cow, Horse, GuineaPig
请注意:预测反应种属仅供参考,不作为质保凭证。
蛋白数据库
基因 ID
免疫原

KLH conjugated synthesised phosphopeptide derived from human PI3 Kinase p110 beta around the phosphorylation site of Ser1070: YR(p-S)

应用 & 推荐
稀释比例
应用 稀释比
WB
WB: 蛋白质免疫印迹
1:500-2000
IHC-P
IHC-P: 石蜡切片样本的免疫组织化学
1:100-500
IHC-F
IHC-F: 冰冻切片样本的免疫组织化学
1:100-500
ICC/IF
ICC/IF: 细胞免疫荧光
1:100-500
敏感性 Endogenous 纯度 affinity purified
偶联 Non-conjugated 修饰 Phosphorylated
同型 IgG  
性状

液体

组分

Supplied in 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

保存条件 & 期限

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

运输条件

Shipping with blue ice.

验证图片
ALL IHC mIHC
  • Immunohistochemical analysis of paraffin-embedded human breast cancer tissue using phospho-PI3 Kinase p110 beta (Ser1070) antibody. The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P81211, 1/100) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with neutral balsam.

  • Immunohistochemical analysis of paraffin-embedded human endometrial cancer tissue using phospho-PI3 Kinase p110 beta (Ser1070) antibody. The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P81211, 1/100) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with neutral balsam.

  • Immunohistochemical analysis of paraffin-embedded human colon cancer tissue using phospho-PI3 Kinase p110 beta (Ser1070) antibody. The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P81211, 1/100) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with neutral balsam.

  • Tyramide signaling amplification based immunofluorescence analysis of paraffin-embedded human breast cancer tissue using phospho-PI3 Kinase p110 beta (Ser1070) antibody. The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P81211, 1/500) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer and fluorescent tyramide signal amplification system.Immunostaining was performed with Vari Fluor 594 TSA (200×)(HY-D1835). Tissues were counterstained with DAPI (blue) and mounted with Anti-fade fluorescence mounting medium.

  • Tyramide signaling amplification based immunofluorescence analysis of paraffin-embedded human endometrial cancer tissue using phospho-PI3 Kinase p110 beta (Ser1070) antibody. The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P81211, 1/500) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer and fluorescent tyramide signal amplification system.Immunostaining was performed with Vari Fluor 594 TSA (200×)(HY-D1835). Tissues were counterstained with DAPI (blue) and mounted with Anti-fade fluorescence mounting medium.

  • Tyramide signaling amplification based immunofluorescence analysis of paraffin-embedded human colon cancer tissue using phospho-PI3 Kinase p110 beta (Ser1070) antibody. The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P81211, 1/500) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer and fluorescent tyramide signal amplification system.Immunostaining was performed with Vari Fluor 594 TSA (200×)(HY-D1835). Tissues were counterstained with DAPI (blue) and mounted with Anti-fade fluorescence mounting medium.

背景
功能:磷脂酰肌醇-3-激酶 (PI3K) 可磷酸化磷脂酰肌醇衍生物的肌醇环 3 位,生成 3-磷酸肌醇 (PubMed:15135396)。PI3K 利用 ATP 和 PtdIns (4,5) P2 (磷脂酰肌醇 4,5-二磷酸) 生成磷脂酰肌醇 3,4,5-三磷酸 (PIP3) (PubMed:15135396)。PIP3 通过将含有 PH 结构域的蛋白质 (包括 AKT1 和 PDPK1) 募集到细胞膜上发挥关键作用,从而激活参与细胞生长、存活、增殖、运动和形态的信号通路。参与 G 蛋白偶联受体 (GPCR) 配体 (如 CXCL12、鞘氨醇-1-磷酸和溶血磷脂酸) 刺激下 AKT1 的激活。也可能作用于下游受体酪氨酸激酶。在不同的血小板稳定黏附和聚集信号通路中发挥作用。参与由 GPCR、α-IIb/β-3 整合素 (ITGA2B/ITGB3) 和含 ITAM (免疫受体酪氨酸激活基序) 的受体 (如 GP6) 触发的血小板激活信号传导。调节 ITGA2B/ITGB3 激活受体的黏附强度,这对于细胞传递收缩力至关重要。是 F2 (凝血酶) 和血栓素 A2 (TXA2) 诱导的血小板聚集所必需的。在细胞存活中发挥作用。可能在细胞迁移中发挥作用。参与自噬体形成的早期阶段。调节细胞内磷脂酰肌醇 3-磷酸 (PtdIns3P) 水平并激活 PIK3C3 激酶活性。可能作为支架蛋白,独立于其脂质激酶活性,正向调控自噬。可能作为支架蛋白参与胰岛素信号通路,而脂质激酶活性并非必需。可能具有不依赖于激酶活性的功能,参与细胞增殖和网格蛋白介导的内吞作用。在缺乏 PTEN 的细胞系中,是致癌信号的介质。脂质激酶活性对其在致癌转化中的作用至关重要。ERBB2 和 RAS 驱动的肿瘤生长需要该蛋白。此外,该蛋白还具有蛋白激酶活性,并表现出自磷酸化 (PubMed:12502714)。
亚细胞定位:细胞质;细胞核
表达水平:
组织特异性:普遍表达
亚基:PIK3CB 催化亚基与 p85 调节亚基 (PIK3R1、PIK3R2 或 PIK3R3) 组成的异二聚体。与 PIK3R2 的相互作用是其核定位和核输出所必需的。
RRID
反应种属数据库
中文名
磷酸化磷脂酰肌醇激酶(PI3Kβ)抗体
同用名
PI3-kinase p110 subunit beta; p-PI3Kβ(Ser1070); PI 3-kinase C2β; p110 BETA; p110Beta; Phosphatidylinositol 3 kinase catalytic beta polypeptide; Phosphatidylinositol 4 5 bisphosphate 3 kinase 110 kDa catalytic subunit beta; Phosphatidylinositol 4 5 bisphosphate 3 kinase catalytic subunit beta isoform; Phosphatidylinositol-4; Phosphoinositide 3 kinase catalytic beta polypeptide; PI3 kinase p110 subunit beta; PI3-kinase subunit beta; PI3K; PI3K beta; PI3K-beta; PI3Kbeta; PI3KCB; PIK3C1; Pik3cb; PK3CB_HUMAN; PtdIns 3 kinase p110; PtdIns-3-kinase subunit beta; PtdIns-3-kinase subunit p110-beta; 5-bisphosphate 3-kinase 110 kDa catalytic subunit beta; 5-bisphosphate 3-kinase catalytic subunit beta isoform.
文件资料

phospho-PI3 Kinase p110 beta (Ser1070) Antibody 相关分类

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
phospho-PI3 Kinase p110 beta (Ser1070) Antibody
目录号:
HY-P81211
需求量: